A meta-analysis and systematic review of different cyclin-dependent kinase 4/6 inhibitors in breast cancer

A meta-analysis and systematic review of different cyclin-dependent kinase 4/6 inhibitors in breast cancer

ObjectiveThe objective of this study was to assess the effectiveness and safety of CDK4/6 inhibitors in the treatment of hormone receptor-positive (HR+) breast cancer by using meta-analysis.MethodsTo gather comprehensive and reliable data for our analysis, we systematically searched multiple databas...

Full description

Bibliographic Details
Main Authors: Jialin Zhang, Xinyu Xu, Yeyue Zhou, Jingyang Su, Jue Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Oncology
Subjects:
breast cancer
CDK4/6 inhibitors
Abemaciclib
Palbociclib
Ribociclib
Dalpiciclib
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1472407/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2025.1472407/full

Similar Items